Bioactive peptides regulate type 2 diabetes by influencing enzymes in carbohydrates metabolism, insulin secretion, and incretin hormones such as GIP and GLP-1, thereby impacting postprandial blood glucose levels. This evidence concerns the gene GCG and type 2 diabetes mellitus.